Clinical trial
A Multicenter, Randomized, Double-blind, Positive-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of WXSH0102 Tablets in the Treatment of Vulvovaginal Candidiasis (VVC)
NCT06771063 is registered in ClinicalTrials.gov with Cisen Pharmaceutical CO., LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Positive-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of WXSH0102 Tablets in the Treatment of Vulvovaginal Candidiasis (VVC)
- Lead sponsor
- Cisen Pharmaceutical CO., LTD.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 13, 2025
- Completion date
- July 31, 2025
- Enrollment
- 108 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.